Weekly update|Companies|Recruiting|Promote|Post a job
Stoke Therapeutics

Stoke Therapeutics

  • Founded: 2014

  • Location: Bedford, MA

  • Employee range: 50 - 200

  • Clinical stage: Clin1/Clin2

  • Therapy area: Dravet syndrome (ODD)

  • Drug types: GEN, NEU, OPH, PED

  • Lead product: STK-001

  • Product link: https://www.stoketherapeutics.com/disease-areas/pipeline/

  • Funding: $97.5M stock Nov 2020; $142M IPO Jun 2019; $90M B Oct 2018; $40M A Jan 2018


stoketherapeutics.com

linkedin.com

job board


Short description:

Antisense Oligonucleotide Medicines

Drug notes:

STK-002 Clin1 autosomal dominant optic atrophy; undisclosed RD SYNGAP1 syndrome; undisclosed RD Rett syndrome; undisclosed RD CNS condition

Long description:

Contact us to add description: recruit@workinbiotech.com

Jobs:

Stoke Therapeutics
Manager, Financial Planning & Analysis
Cambridge, MA|9 days ago
Apply
Stoke Therapeutics
Associate Director, Pharmacovigilance
Cambridge, MA|9 days ago
Stoke Therapeutics
Sr. Corporate Counsel, Clinical Research and Devel...
Cambridge, MA|36 days ago
Stoke Therapeutics
Associate Director, Quality Operations
Cambridge, MA|44 days ago
Stoke Therapeutics
Associate Director/Director, Oligonucleotide Medic...
Cambridge, MA|45 days ago
Stoke Therapeutics
Sr. Director/Executive Director, Global Medical Co...
Cambridge, MA|46 days ago
Stoke Therapeutics
Director, Medical Writing - Regulatory & Clinical
Cambridge, MA|46 days ago


Main
Home

Weekly update

Companies

Recruiting

Promote

Claim your company
© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com